Steigerwald, Gordon & Koch Inc. Elanco Animal Health Inc Transaction History
Steigerwald, Gordon & Koch Inc.
- $977 Million
- Q3 2025
A detailed history of Steigerwald, Gordon & Koch Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Steigerwald, Gordon & Koch Inc. holds 550 shares of ELAN stock, worth $12,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
550Holding current value
$12,248% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELAN
# of Institutions
433Shares Held
485MCall Options Held
868KPut Options Held
1.42M-
Dodge & Cox San Francisco, CA82.9MShares$1.85 Billion0.71% of portfolio
-
Primecap Management CO Pasadena, CA51.8MShares$1.15 Billion0.6% of portfolio
-
Vanguard Group Inc Valley Forge, PA47.8MShares$1.07 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$519 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX22.7MShares$507 Million0.08% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $10.6B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...